BioSpace News Archive

Kuria Therapeutics is pleased to announce it has completed a pre-Investigational New Drug (“IND”) interaction with the U.S. Food and Drug Administration (FDA) and received positive feedback on its development program for KTX-1161 for corneal endothelial disease.

The Porex Life Sciences Institute announced today during the 2023 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting that it is expanding the availability of its Saletto® Oral Fluid Collection Device to the genetic and genomic testing market.

According the latest data released at the Clinical Trials Implied Approval section on the website of China’s Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), Likang Life Sciences (hereinafter referred to as “Likang”) has received implied approval for the clinical trial of its personalized neoantigen-targeted vaccine for advanced solid tumors, LK101 Injection.

RVAC Medicines (US), Inc. today announced the collaboration under a Sponsored Research Agreement with the University of Pennsylvania (“Penn”) focused on the discovery and development of mRNA vaccines that can modulate the body’s normal immune response as possible treatments for certain autoimmune diseases and allergic conditions.

Hanmi Pharmaceuticals (128940.KS), a subsidiary of Hanmi Science (008930.KS) in Korea, announced that the results of large-scale clinical trial with Rosuzet have been published in ‘The Lancet’ and the ‘European Heart Journal’.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced three presentations on amyotrophic lateral sclerosis (ALS) as part of the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, being held virtually and in Dallas, Tex., March 19-22.

BRAINBox Solutions today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance to issue to the company a broad patent covering a specific set of biomarkers that correlate to specific neuroimaging findings by standard or advanced MRI methods.

Biostarks, a digital health company, is pleased to announce the launch of its innovative at-home longevity test kits.

Three new officers and four new board members will be installed immediately upon conclusion of the 2023 Annual Meeting of the American Academy of Dermatology, the world’s largest dermatologic society.

Alvotech (NASDAQ: ALVO) today announced the presentation of two posters related to its clinical studies in support of biosimilarity and clinical comparability of Alvotech’s ATV04 (ustekinumab) and the reference product Stelara® at the 2023 American Academy of Dermatology (AAD) Annual Meeting, March 17-21 in New Orleans.